Blood-nourishing and hard-softening capsule costs less in the management of osteoarthritic knee pain: A randomized controlled trial

Keyphrases

• Confidence Interval 100%
• Randomized Controlled Trial 100%
• Knee Pain 100%
• Knee Osteoarthritis 100%
• Stiffness 66%
• Functional Capacity 66%
• Pain Level 66%
• WOMAC 66%
• Copyright 33%
• No Significant Difference 33%
• Statistical Analysis 33%
• Pain Relief 33%
• Placebo Groups 33%
• Western Ontario 33%
• Primary Outcome Measure 33%
• Inflammation 33%
• Western Medicine 33%
• Teaching Hospital 33%
• Mixed Models 33%
• McMaster University 33%
• Commonly Prescribed Drugs 33%
• Traditional Chinese Drugs 33%
• Herbal Drugs 33%
• Disease Symptoms 33%
• Self-reported Pain 33%
• Severe Adverse Effects 33%
• Chondroprotection 33%
• Prescription Drugs 33%
• Osteoarthritis 33%
• Chinese Formulas 33%

Nursing and Health Professions

• Confidence Interval 100%
• Knee Pain 100%
• Microcapsule 100%
• Rigidity 66%
• Western Ontario and McMaster Universities Osteoarthritis Index 66%
• Disease 33%
• Adverse Event 33%
• Symptom 33%
• Inflammation 33%
• Placebo 33%
• Palliative Therapy 33%
• Osteoarthritis 33%
• Herbaceous Agent 33%
• Knee Osteoarthritis 33%
• Teaching Hospital 33%
• Chinese Drug 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Knee Pain 100%
• Symptom 50%
• Disease 50%
• Adverse Event 50%
• Inflammation 50%
• Placebo 50%
• Osteoarthritis 50%
• Knee Osteoarthritis 50%
• Mixed Model 50%
• Herbaceous Agent 50%
• Chinese Drug 50%